Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Störk

Showing results (1-10 of 393) with videos related to

Pageof 40
Sort By:
The Lancet. Diabetes & Endocrinology|June 24, 2018
Renal effects of sacubitril/valsartan in patients with diabetesStefan Störk
European Heart Journal|July 19, 2024
Pulmonary artery pressure-guided heart failure care: the setting mattersStefan Störk
European Heart Journal|February 25, 2025
Suspected heart failure: a clinical pattern that calls for actionStefan Störk
Journal of the American College of Cardiology|October 29, 2025
Outpatient Worsening in HFrEF: A Signal, Not a StandardStefan Störk
Deutsche Medizinische Wochenschrift (1946)|February 27, 2024
[Update: Heart Failure with Preserved Ejection Fraction]Caroline Morbach, Stefan Störk
Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Current therapy of heart failure with mildly reduced or preserved left ventricular ejection fraction]Stefan Störk, Caroline Morbach
European Journal of Heart Failure|April 9, 2026
From evidence to adoption: lessons from the OPTIPHARM-HF registryStefan Störk, Birgit Aßmus
European Journal of Heart Failure|April 20, 2026
Beyond phenogroups: towards a continuous biology of HFpEFStefan Störk, Hiroaki Shimokawa
International Journal of Cardiology|May 13, 2015
The role of circulatory power and cardiac reserve in reverse epidemiology - Assessing heart failure severityGülmisal Güder, Stefan Störk
Innere Medizin (Heidelberg, Germany)|July 10, 2025
[Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and obesity-the cardiometabolic turnaround?]Stefan Störk, Sirka Nitschmann
Pageof 40

Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
The Lancet. Diabetes & Endocrinology|June 24, 2018
Renal effects of sacubitril/valsartan in patients with diabetesStefan Störk
European Heart Journal|July 19, 2024
Pulmonary artery pressure-guided heart failure care: the setting mattersStefan Störk
European Heart Journal|February 25, 2025
Suspected heart failure: a clinical pattern that calls for actionStefan Störk
Journal of the American College of Cardiology|October 29, 2025
Outpatient Worsening in HFrEF: A Signal, Not a StandardStefan Störk
Deutsche Medizinische Wochenschrift (1946)|February 27, 2024
[Update: Heart Failure with Preserved Ejection Fraction]Caroline Morbach, Stefan Störk
Deutsche Medizinische Wochenschrift (1946)|January 29, 2024
[Current therapy of heart failure with mildly reduced or preserved left ventricular ejection fraction]Stefan Störk, Caroline Morbach
European Journal of Heart Failure|April 9, 2026
From evidence to adoption: lessons from the OPTIPHARM-HF registryStefan Störk, Birgit Aßmus
European Journal of Heart Failure|April 20, 2026
Beyond phenogroups: towards a continuous biology of HFpEFStefan Störk, Hiroaki Shimokawa
International Journal of Cardiology|May 13, 2015
The role of circulatory power and cardiac reserve in reverse epidemiology - Assessing heart failure severityGülmisal Güder, Stefan Störk
Innere Medizin (Heidelberg, Germany)|July 10, 2025
[Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and obesity-the cardiometabolic turnaround?]Stefan Störk, Sirka Nitschmann
Pageof 40